Omega-3 fatty acids offer numerous health benefits; their EPA/DHA content has the ability to reduce the level of unwanted cholesterol (LDL) in the human body, thereby leading to lower coronary heart diseases and blood pressure disorders. Thus, growing awareness of diet intake to ensure a healthy lifestyle is expected to be the key driving force for the market.
Infant formula—a significant application of omega-3s—has witnessed noticeable attention in recent years. Considerable amounts of infant formulations are being devised by using EPA/DHA because of their significant health benefits. As a result, companies such as Nestle and Similac have been progressively increasing product lines for this segment. Thus, growing awareness of these benefits is expected to boost the market over the next six years.
Indications & Claims
Approved health claims in the EU and elsewhere are also expected to impact the market over the forecast period. However, the lack of recommended dietary intake (RDI) levels is expected to be a challenge for market growth.
Demand for omega-3s to prevent or mitigate diseases such as cancer, cardiovascular diseases, inflammation, development disorders, mental health and cognitive aging is on the rise. In addition, omega-3 fatty acids are used to support the health of eyes, brain and nerves in children up to 12 years of age.
Europe was the largest consumer of omega-3s with a share of more than 60% in 2012, followed by North America. Regulations favoring the usage of omega-3s in functional food and infant formula are expected to spur demand for these ingredients in developed markets.
High birth rates in countries such as India and China will also boost demand for omega-3 ingredients in applications such as infant formula. In addition, evolving lifestyles have led to increased focus on health, particularly coronary heart diseases, which have directly impacted demand for omega-3 products.
For more information: https://www.grandviewresearch.com/industry-analysis/omega-3-market